IMIC" (Innovative Movement Therapy in Childhood) is a translational research and development project that is specialized in creating a motivating locomotion rehabilitation setting for children with neurological disorders and cognitive limitations in an interdisciplinary context. "IMIC" was founded in 2010 by an interdisciplinary cooperation of movement scientists, neurologists and neuropsychologists (Zurich University Children's Hospital / Rehab Research Group, Rehabilitation Centre Affoltern a. Albis), game designers (ZHdK Zurich University of the Arts / Specialization in Game Design) and specialists in sensory-motor robotics (ETH Zurich / SensoryMotor Systems Laburich University ). The project focuses on the expansion of pediatric robot-assisted rehabilitation, which is achieved through the flexible connection of specifically designed RehabGame scenarios to various therapy devices for upper and lower extremities. The project's key development, the middleware "RehabConnex", allows the combination of several therapy robots or input devices, or respectively a combination of both to the "IMIC"-RehabGames. "IMIC" makes use of the rehabilitation robots Lokomat® (Hocoma) and ChARMin (ETH Zurich) to function as multimodal "game controllers", which translate the patient's physical input into game control parameters. Beside clinical research questions addressing the impact of the developments, "IMIC" focuses on design aspects and technological research and development: Which gameconceptual, audio-visual and technological features must a RehabGame provide in order to maximally motivate young patients in their active participation in therapy as well as to support the therapists?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.